Evogene (EVGN) Earnings Analysis

Evogene (EVGN) next reports earnings on 2026-08-26, consensus EPS -0.27 USD. Last quarter (2026-05-20) it missed with EPS -0.6 USD vs -0.27 USD est (-122.2%). It has beaten estimates in 2/7 recent quarters (29%). Trailing P/E -0.40.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does EVGN next report earnings?

Next earnings date2026-08-26
Consensus EPS estimate-0.27 USD
Revenue estimate0.00B

EVGN earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-20-0.6 USD-0.27 USD-122.2%Miss
2026-03-05-0.61 USD-0.26 USD-134.6%Miss
2025-11-20-0.31 USD-0.26 USD-19.2%Miss
2025-08-28-1.06 USDn/an/an/a
2025-05-21-0.38 USD-0.625 USD+39.2%Beat
2025-03-060.06 USD-0.72 USD+108.3%Beat
2024-11-21-1.31 USD-1.01 USD-29.7%Miss
2024-08-22-1.06 USD-0.12 USD-783.3%Miss

Beat rate: 2/7 (29%) over reported quarters with consensus data.

EVGN valuation and analyst view

Trailing P/E-0.40
Trailing EPS-1.21206 USD
Price / book-2.13
Dividend yield0.00%
Market cap0.00B
Analyst consensusBuy (4 buy / 0 hold / 0 sell)
Avg price target2.15 USD

Related research pages

Frequently asked questions

When is Evogene (EVGN)'s next earnings date?

Evogene is next scheduled to report on 2026-08-26, with a consensus EPS estimate of -0.27 USD and revenue estimate of 0.00B.

Did EVGN beat earnings last quarter?

In its 2026-05-20 report, EVGN posted EPS of -0.6 USD versus a -0.27 USD estimate — a miss of 122.2%.

What is EVGN's earnings track record?

Over the last 7 reported quarters with consensus data, EVGN beat estimates 2 times (29%).

What is EVGN's current P/E ratio and EPS?

EVGN trades at a trailing P/E of -0.40 on trailing EPS of -1.2120606968225076 USD.

What do analysts rate EVGN?

Analyst consensus is "Buy" across 4 ratings (0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 2.15 USD.